Paola Guglielmelli (P Guglielmelli)

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2016-2023
Publications (10 Years): 64

Top Venues

Blood cancer journal

American journal of hematology

Leukemia

Hematological oncology

Azienda Ospedaliero Universitaria Careggi

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Azienda Ospedaliero Universitaria Careggi Jul 1o 2015

Italy

MEDICO EMATOLOGO :: ONCOLOGIA

Publications

Paola Guglielmelli, Chiara Maccari, Benedetta Sordi, Manjola Balliu, Alessandro Atanasio, Carmela Mannarelli, Giulio Capecchi, Ilaria Sestini, Giacomo Coltro, Giuseppe Gaetano Loscocco, Giada Rotunno, Eva Angori, Filippo C Borri, Ayalew Tefferi, Alessandro Maria Maria Vannucchi
Phenotypic correlations of CALR mutation variant allele frequency in patients with myelofibrosis. Blood cancer journal 13 (1) (2023)
Paola Guglielmelli, Chiara Maccari, Benedetta Sordi, Manjola Balliu, Alessandro Atanasio, Carmela Mannarelli, Giulio Capecchi, Ilaria Sestini, Giacomo Coltro, Giuseppe Gaetano Loscocco, Giada Rotunno, Eva Angori, Filippo C Borri, Ayalew Tefferi, Alessandro Maria Maria Vannucchi
Phenotypic correlations of CALR mutation variant allele frequency in patients with myelofibrosis. Blood cancer journal 13 (1) (2023)
Paola Guglielmelli, Chiara Maccari, Benedetta Sordi, Manjola Balliu, Alessandro Atanasio, Carmela Mannarelli, Giulio Capecchi, Ilaria Sestini, Giacomo Coltro, Giuseppe Gaetano Loscocco, Giada Rotunno, Eva Angori, Filippo C Borri, Ayalew Tefferi, Alessandro Maria Maria Vannucchi
Phenotypic correlations of CALR mutation variant allele frequency in patients with myelofibrosis. Blood cancer journal 13 (1) (2023)
Francesca Palandri, Haifa Kathrin Al-Ali, Paola Guglielmelli, Mike W Zuurman, Rajendra Sarkar, Vikas K Gupta
Benefit of Early Ruxolitinib Initiation Regardless of Fibrosis Grade in Patients with Primary Myelofibrosis: A Post Hoc Analysis of the Single-Arm Phase 3b JUMP Study. Cancers 15 (10) (2023)
Elisa Bianchi, Sebastiano Rontauroli, Lara Tavernari, Margherita Mirabile, Francesca Pedrazzi, Elena Genovese, Stefano Sartini, Massimiliano Dall'Ora, Giulia Grisendi, Luca Fabbiani, Monica Maccaferri, Chiara Carretta, Sandra Parenti, Sebastian Fantini, Niccolo Bartalucci, Laura Calabresi, Manjola Balliu, Paola Guglielmelli, Leonardo Potenza, Enrico Tagliafico, Lorena Losi, Massimo Dominici, Mario Luppi, Alessandro Maria Vannucchi, Rossella Manfredini
Inhibition of ERK1/2 signaling prevents bone marrow fibrosis by reducing osteopontin plasma levels in a myelofibrosis mouse model. Leukemia (2023)
Paola Guglielmelli, Chiara Maccari, Benedetta Sordi, Manjola Balliu, Alessandro Atanasio, Carmela Mannarelli, Giulio Capecchi, Ilaria Sestini, Giacomo Coltro, Giuseppe Gaetano Loscocco, Giada Rotunno, Eva Angori, Filippo C Borri, Ayalew Tefferi, Alessandro Maria Maria Vannucchi
Phenotypic correlations of CALR mutation variant allele frequency in patients with myelofibrosis. Blood cancer journal 13 (1) (2023)
Francesco Mannelli, Francesca Crupi, Roberta Zanotti, Livio Pagano, Davide Rapezzi, Ilaria Tanasi, Marianna Criscuolo, Massimiliano Bonifacio, Alberto Fresa, Paola Guglielmelli, Alessandro M Vannucchi
The clinical experience of compassionate use program for avapritinib: implications for drug positioning in the therapeutic scenario of systemic mastocytosis. Therapeutic advances in hematology 14 (2023)
Paola Guglielmelli, Giacomo Coltro, Francesco Mannelli, Giada Rotunno, Giuseppe Gaetano Loscocco, Carmela Mannarelli, Chiara Maccari, Chiara Paoli, Simone Romagnoli, Niccolo Bartalucci, Alessandro Maria Maria Vannucchi
ASXL1 mutations are prognostically significant in PMF, but not MF following essential thrombocythemia or polycythemia vera. Blood advances 6 (9) (2022)
Elena Genovese, Margherita Mirabile, Sebastiano Rontauroli, Stefano Sartini, Sebastian Fantini, Lara Tavernari, Monica Maccaferri, Paola Guglielmelli, Elisa Bianchi, Sandra Parenti, Chiara Carretta, Selene Mallia, Sara Castellano, Corrado Colasante, Manjola Balliu, Niccolò Bartalucci, Raffaele Palmieri, Tiziana Ottone, Barbara Mora, Leonardo Potenza, Francesco Passamonti, Maria Teresa Teresa Voso, Mario Luppi, Alessandro Maria Maria Vannucchi, Enrico Tagliafico, Rossella Manfredini, null On Behalf Of The Mynerva MYeloid NEoplasms Research Venture Airc
The Response to Oxidative Damage Correlates with Driver Mutations and Clinical Outcome in Patients with Myelofibrosis. Antioxidants (Basel, Switzerland) 11 (1) (2022)
Paola Guglielmelli, Jean-Jacques Kiladjian, Alessandro M Vannucchi, Minghui Duan, Haitao Meng, Ling Pan, Guang-Sheng He, Srdan Verstovsek, Françoise Boyer, Fiorenza Barraco, Dietger Niederwieser, Ester Pungolino, Anna Marina Liberati, Claire Harrison, Pantelia Roussou, Monika Wroclawska, Divyadeep Karumanchi, Karen Sinclair, Peter A W Te Boekhorst, Heinz Gisslinger
Efficacy and safety of ruxolitinib in patients with myelofibrosis and low platelet count (50 × 10 9 /L to <100 × 10 9 /L) at baseline: the final analysis of EXPAND. Therapeutic advances in hematology 13 (2022)
Massimo Breccia, A Piciocchi, Monica Messina, S Soddu, V De Stefano, M Bellini, A Iurlo, B Martino, S Siragusa, F Albano, B Mora, P Fazi, M Vignetti, Paola Guglielmelli, Francesca Palandri
Covid-19 in Philadelphia-negative myeloproliferative neoplasms: a GIMEMA survey on incidence, clinical management and vaccine. Leukemia 36 (10) (2022)
Tiziano Barbui, Arianna Ghirardi, Alessandra Carobbio, Arianna Masciulli, Greta Carioli, Alessandro Rambaldi, Maria Chiara Finazzi, Marta Bellini, Elisa Rumi, Daniele Vanni, Oscar Borsani, Francesco Passamonti, Barbara Mora, Marco Brociner, Paola Guglielmelli, Chiara Paoli, Alberto Alvarez-Larran, Ana Triguero, Marta Garrote, Helna Pettersson, Björn Andréasson, Giovanni Barosi, Alessandro Maria Maria Vannucchi
Increased risk of thrombosis in JAK2 V617F-positive patients with primary myelofibrosis and interaction of the mutation with the IPSS score. Blood cancer journal 12 (11) (2022)
Alessandra Carobbio, Alessandro Maria Vannucchi, Valerio De Stefano, Arianna Masciulli, Paola Guglielmelli, Giuseppe Gaetano Loscocco, Francesco Ramundo, Elena Rossi, Yogendra Kanthi, Ayalew Tefferi, Tiziano Barbui
Neutrophil-to-lymphocyte ratio is a novel predictor of venous thrombosis in polycythemia vera. Blood cancer journal 12 (2) (2022)
Tiziano Barbui, Alessandra Iurlo, Arianna Masciulli, Alessandra Carobbio, Arianna Ghirardi, Greta Carioli, Marta Anna Sobas, Elena Maria Elli, Elisa Rumi, Valerio De Stefano, Francesca Lunghi, Monia Marchetti, Rosa Daffini, Mercedes Gasior Kabat, Beatriz Cuevas, Maria Laura Fox, Marcio Miguel Andrade-Campos, Francesca Palandri, Paola Guglielmelli, Giulia Benevolo, Claire Harrison, Maria Angeles Foncillas, Massimiliano Bonifacio, Alberto Alvarez-Larran, Jean-Jacques Kiladjian, Estefanía Bolaños Calderón, Andrea Patriarca, Keina Susana Quiroz Cervantes, Martin Griessammer, J Valentín García-Gutiérrez, Alberto Marin Sanchez, Elena Magro Mazo, Marco Ruggeri, Juan Carlos Carlos Hernández-Boluda, Santiago Osorio, Gonzalo Carreno-Tarragona, Miguel Sagues Serrano, Rajko Kusec, Begona Navas Elorza, Anna Angona, Blanca Xicoy Cirici, Emma Lopez Abadia, Steffen Koschmieder, Daniele Cattaneo, Cristina Bucelli, Edyta Cichocka, Anna Masternak Kulikowska de Nałęcz, Fabrizio Cavalca, Oscar Borsani, Silvia Betti, Lina Benajiba, Marta Bellini, Natalia Curto-Garcia, Alessandro Rambaldi, Alessandro Maria Vannucchi
Second versus first wave of COVID-19 in patients with MPN. Leukemia 36 (3) (2022)
Massimo Breccia, Francesca Palandri, Paola Guglielmelli, Giuseppe Alberto Maria Palumbo, Alessandra Malato, Francesco Mendicino, Alessandra Ricco, Emanuela Sant'Antonio, Mario Tiribelli, Alessandra Iurlo
Management of Myelofibrosis during Treatment with Ruxolitinib: A Real-World Perspective in Case of Resistance and/or Intolerance. Current oncology (Toronto, Ont.) 29 (7) (2022)
Tiziano Barbui, Alessandra Carobbio, Arianna Ghirardi, Alessandra Iurlo, Valerio De Stefano, Marta Anna Sobas, Elisa Rumi, Elena Maria Elli, Francesca Lunghi, Mercedes Gasior Kabat, Beatriz Cuevas, Paola Guglielmelli, Massimiliano Bonifacio, Monia Marchetti, Alberto Alvarez-Larran, Laura Fox, Marta Bellini, Rosa Daffini, Giulia Benevolo, Gonzalo Carreno-Tarragona, Andrea Patriarca, Haifa Kathrin Al-Ali, Maria Marcio Miguel Andrade-Campos, Francesca Palandri, Claire Harrison, Maria Angeles Foncillas, Santiago Osorio, Steffen Koschmieder, Elena Magro Mazo, Jean-Jacques Kiladjian, Estefanía Bolaños Calderón, Florian H Heidel, Keina Susana Quiroz Cervantes, Martin Griesshammer, J Valentín García-Gutiérrez, Alberto Marin Sanchez, Juan Carlos Carlos Hernández-Boluda, Emma Lopez Abadia, Giuseppe Carli, Miguel Sagues Serrano, Rajko Kusec, Blanca Xicoy Cirici, Margarita Guenova, Begona Navas Elorza, Anna Angona, Edyta Cichocka, Anna Kulikowska de Nałęcz, Daniele Cattaneo, Cristina Bucelli, Silvia Betti, Oscar Borsani, Fabrizio Cavalca, Sara Carbonell, Natalia Curto-Garcia, Lina Benajiba, Alessandro Rambaldi, Alessandro Maria Vannucchi
Breakthrough infections in MPN-COVID vaccinated patients. Blood cancer journal 12 (11) (2022)
Barbara Mora, Paola Guglielmelli, Andrew Kuykendall, Elisa Rumi, Margherita Maffioli, Francesca Palandri, Valerio De Stefano, Marianna Caramella, Silvia Salmoiraghi, Jean-Jacques Kiladjian, Jason Gotlib, Alessandra Iurlo, Francisco Cervantes, Marco Ruggeri, Richard T Silver, Francesco Albano, Giulia Benevolo, David Morrall Ross, Matteo G Della Porta, Timothy Devos, Giada Rotunno, Rami S Komrokji, Ilaria C Casetti, Michele Merli, Marco Brociner, Domenica Caramazza, Giuseppe Auteri, Tiziano Barbui, Daniele Cattaneo, Lorenza Bertù, Luca Arcaini, Alessandro M Vannucchi, Francesco Passamonti
Prediction of thrombosis in post-polycythemia vera and post-essential thrombocythemia myelofibrosis: a study on 1258 patients. Leukemia 36 (10) (2022)
Giuseppe Gaetano Loscocco, Paola Guglielmelli, Naseema Gangat, Elena Rossi, Carmela Mannarelli, Silvia Betti, Chiara Maccari, Francesco Ramundo, Yamna Jadoon, Francesca Gesullo, Sara Ceglie, Chiara Paoli, Animesh D Pardanani, Valerio De Stefano, Ayalew Tefferi, Alessandro Maria Maria Vannucchi
Clinical and molecular predictors of fibrotic progression in essential thrombocythemia: A multicenter study involving 1607 patients. American journal of hematology 96 (11) (2021)
Francesco Passamonti, Vikas Gupta, Bruno Martino, Lynda Foltz, Andrey Zaritskey, Haifa Kathrin Al-Ali, Renato Tavares, Margherita Maffioli, Pia Raanani, Pilar Giraldo, Martin Griesshammer, Paola Guglielmelli, Catherine Bouard, Carole Paley, Ranjan Tiwari, Alessandro M Vannucchi
Comparing the safety and efficacy of ruxolitinib in patients with Dynamic International Prognostic Scoring System low-, intermediate-1-, intermediate-2-, and high-risk myelofibrosis in JUMP, a Phase 3b, expanded-access study. Hematological oncology 39 (4) (2021)
Tiziano Barbui, Alessandro Maria Vannucchi, Alberto Alvarez-Larran, Alessandra Iurlo, Arianna Masciulli, Alessandra Carobbio, Arianna Ghirardi, Alberto Ferrari, Giuseppe Rossi, Elena Elli, Marcio Miguel Andrade-Campos, Mercedes Gasior Kabat, Jean-Jaques Kiladjian, Francesca Palandri, Giulia Benevolo, Valentin Garcia-Gutierrez, Maria Laura Fox, Maria Angeles Foncillas, Carmen Montoya Morcillo, Elisa Rumi, Santiago Osorio, Petros Papadopoulos, Massimiliano Bonifacio, Keina Susana Quiroz Cervantes, Miguel Sagues Serrano, Gonzalo Carreno-Tarragona, Marta Anna Sobas, Francesca Lunghi, Andrea Patriarca, Begona Navas Elorza, Anna Angona, Elena Magro Mazo, Steffen Koschmieder, Marco Ruggeri, Beatriz Cuevas, Juan Carlos Carlos Hernández-Boluda, Emma Lopez Abadia, Blanca Xicoy Cirici, Paola Guglielmelli, Marta Garrote, Daniele Cattaneo, Rosa Daffini, Fabrizio Cavalca, Beatriz Bellosillo, Lina Benajiba, Natalia Curto-Garcia, Marta Bellini, Silvia Betti, Valerio De Stefano, Claire Harrison, Alessandro Rambaldi
High mortality rate in COVID-19 patients with myeloproliferative neoplasms after abrupt withdrawal of ruxolitinib. Leukemia 35 (2) (2021)
Tiziano Barbui, Alessandra Iurlo, Arianna Masciulli, Alessandra Carobbio, Arianna Ghirardi, Giuseppe Rossi, Claire Harrison, Alberto Alvarez-Larran, Elena Maria Elli, Jean-Jaques Kiladjian, Mercedes Gasior Kabat, Alberto Marin Sanchez, Francesca Palandri, Marcio Miguel Andrade-Campos, Alessandro Maria Vannucchi, Gonzalo Carreno-Tarragona, Petros Papadopoulos, Keina Susana Quiroz Cervantes, Maria Angeles Foncillas, Maria Laura Fox, Miguel Sagues Serrano, Elisa Rumi, Santiago Osorio, Giulia Benevolo, Andrea Patriarca, Begona Navas Elorza, Valentin Garcia-Gutierrez, Elena Magro Mazo, Francesca Lunghi, Massimiliano Bonifacio, Valerio De Stefano, Juan Carlos Carlos Hernández-Boluda, Emma Lopez Abadia, Anna Angona, Blanca Xicoy Cirici, Marco Ruggeri, Steffen Koschmieder, Marta Anna Sobas, Beatriz Cuevas, Daniele Cattaneo, Rosa Daffini, Marta Bellini, Natalia Curto-Garcia, Marta Garrote, Fabrizio Cavalca, Lina Benajiba, Beatriz Bellosillo, Paola Guglielmelli, Oscar Borsani, Silvia Betti, Silvia Salmoiraghi, Alessandro Rambaldi
Long-term follow-up of recovered MPN patients with COVID-19. Blood cancer journal 11 (6) (2021)
Naseema Gangat, Paola Guglielmelli, Aref A Al-Kali, Alexandra P Wolanskyj-Spinner, John Camoriano, Mrinal M Patnaik, Animesh D Pardanani, Curtis A Hanson, Alessandro M Vannucchi, Ayalew Tefferi
Pregnancy in patients with myelofibrosis: Mayo-Florence series of 24 pregnancies in 16 women. British journal of haematology 195 (1) (2021)
Paola Guglielmelli, Naseema Gangat, Giacomo Coltro, Terra L Lasho, Giuseppe Gaetano Loscocco, Christy M Finke, Erika Morsia, Benedetta Sordi, Natasha Szuber, Curtis A Hanson, Animesh Pardanani, Alessandro M Vannucchi, Ayalew Tefferi
Mutations and thrombosis in essential thrombocythemia. Blood cancer journal 11 (4) (2021)
Giuseppe Gaetano Loscocco, Elisabetta Antonioli, Ilaria Romano, Federica Vergoni, Giada Rotunno, Francesco Mannelli, Paola Guglielmelli, Alessandro Maria Maria Vannucchi
Lenalidomide: A double-edged sword for concomitant multiple myeloma and post-essential thrombocythemia myelofibrosis. American journal of hematology 96 (6) (2021)
Paola Guglielmelli, Giuseppe Gaetano Loscocco, Carmela Mannarelli, Elena Rossi, Francesco Mannelli, Francesco Ramundo, Giacomo Coltro, Silvia Betti, Chiara Maccari, Sara Ceglie, Patrizia Chiusolo, Chiara Paoli, Tiziano Barbui, Ayalew Tefferi, Valerio De Stefano, Alessandro Maria Maria Vannucchi
JAK2V617F variant allele frequency >50% identifies patients with polycythemia vera at high risk for venous thrombosis. Blood cancer journal 11 (12) (2021)
Paola Guglielmelli, Arianna Ghirardi, Alessandra Carobbio, Arianna Masciulli, Chiara Maccari, Barbara Mora, Elisa Rumi, Ana Triguero, Maria Chiara Finazzi, Helna Pettersson, Chiara Paoli, Francesco Mannelli, Daniele Vanni, Alessandro Rambaldi, Francesco Passamonti, Alberto Alvarez-Larran, Bjorn I Andreasson, Alessandro Maria Maria Vannucchi, Tiziano Barbui
Impact of ruxolitinib on survival of patients with myelofibrosis in the real world: update of ERNEST Study. Blood advances (2021)
Tiziano Barbui, Valerio De Stefano, Alberto Alvarez-Larran, Alessandra Iurlo, Arianna Masciulli, Alessandra Carobbio, Arianna Ghirardi, Alberto Ferrari, Valeria Cancelli, Elena Maria Elli, Marcio Miguel Andrade-Campos, Mercedes Gasior Kabat, Jean-Jaques Kiladjian, Francesca Palandri, Giulia Benevolo, J Valentín García-Gutiérrez, Maria Laura Fox, Maria Angeles Foncillas, Carmen Montoya Morcillo, Elisa Rumi, Santiago Osorio, Petros Papadopoulos, Massimiliano Bonifacio, Keina Susana Quiroz Cervantes, Miguel Sagues Serrano, Gonzalo Carreno-Tarragona, Marta Anna Sobas, Francesca Lunghi, Andrea Patriarca, Begoña Navas Elorza, Anna Angona, Elena Magro Mazo, Steffen Koschmieder, Giuseppe Carli, Beatriz Cuevas, Juan Carlos Carlos Hernández-Boluda, Emma Lopez Abadia, Blanca Xicoy Cirici, Paola Guglielmelli, Marta Garrote, Daniele Cattaneo, Rosa Daffini, Fabrizio Cavalca, Beatriz Bellosillo, Lina Benajiba, Natalia Curto-Garcia, Marta Bellini, Silvia Betti, Claire Harrison, Alessandro Rambaldi, Alessandro Maria Vannucchi
Among classic myeloproliferative neoplasms, essential thrombocythemia is associated with the greatest risk of venous thromboembolism during COVID-19. Blood cancer journal 11 (2) (2021)
Naseema Gangat, Paola Guglielmelli, Natasha Szuber, Kebede H Begna, Mirinal S Patnaik, Mark R Litzow, Aref Al-Kali, James M Foran, Jeanne M Palmer, Hassan Alkhateeb, Michelle A Elliott, Curtis A Hanson, Animesh D Pardanani, Francesco Mannelli, Alessandro Maria Maria Vannucchi, Ayalew Tefferi
Venetoclax with azacitidine or decitabine in blast-phase myeloproliferative neoplasm: A multicenter series of 32 consecutive cases. American journal of hematology 96 (7) (2021)
Alessandra Carobbio, Paola Guglielmelli, Elisa Rumi, Chiara Cavalloni, Valerio De Stefano, Silvia Betti, Alessandro Rambaldi, Maria Chiara Finazzi, Juergen Thiele, Alessandro M Vannucchi, Ayalew Tefferi, Tiziano Barbui
A multistate model of survival prediction and event monitoring in prefibrotic myelofibrosis. Blood cancer journal 10 (10) (2020)
Giuseppe Gaetano Loscocco, Danilo Malandrino, Simone Barchiesi, Andrea Berni, Loredana Poggesi, Paola Guglielmelli, Alessandro Maria Maria Vannucchi
The HScore for secondary hemophagocytic lymphohistiocytosis, calculated without a marrow biopsy, is consistently low in patients with COVID-19. International journal of laboratory hematology 42 (6) (2020)
Giuseppe Gaetano Loscocco, Francesco Mannelli, Lara Mannelli, Federica Vergoni, Francesca Gesullo, Giada Rotunno, Paola Guglielmelli, Alessandro Maria Maria Vannucchi
A case of aleukemic mast cell leukemia with an underlying myeloproliferative neoplasm: Morphological and molecular characteristics of a highly aggressive disease. American journal of hematology 95 (12) (2020)
Ayalew Tefferi, Paola Guglielmelli, Terra L Lasho, Giacomo Coltro, Christy M Finke, Giuseppe G Loscocco, Benedetta Sordi, Natasha Szuber, Giada Rotunno, Annalisa Pacilli, Curtis A Hanson, Rhett P Ketterling, Animesh Pardanani, Naseema Gangat, Alessandro M Vannucchi
Mutation-enhanced international prognostic systems for essential thrombocythaemia and polycythaemia vera. British journal of haematology 189 (2) (2020)
Alberto Quattrocchi, Carlo Maiorca, Monia Billi, Simona Tomassini, Elisabetta De Marinis, Natalia Cenfra, Francesco Equitani, Martina Gentile, Alessia Ceccherelli, Cristina Banella, Sergio Mecarocci, Maria Cristina Scerpa, Stefania Pisanò, Annalisa Pacilli, Claudio Di Cristofano, Massimiliano Mancini, Paola Guglielmelli, Alessandro Maria Vannucchi, Nelida Noguera, Francesco Grignani, Giuseppe Cimino, Clara Nervi
Genetic lesions disrupting calreticulin 3'-untranslated region in JAK2 mutation-negative polycythemia vera. American journal of hematology (2020)
Alessandro Maria Maria Vannucchi, Benedetta Sordi, Alessandro Morettini, Carlo Nozzoli, Loredana Poggesi, Filippo Pieralli, Alessandro Bartoloni, Alessandro Atanasio, Filippo Miselli, Chiara Paoli, Giuseppe Gaetano Loscocco, Andrea Fanelli, Ombretta Para, Andrea Berni, Irene Tassinari, Lorenzo Zammarchi, Laura Maggi, Alessio Mazzoni, Valentina Scotti, Giorgia Falchetti, Danilo Malandrino, Fabio Luise, Giovanni Millotti, Sara Bencini, Manuela Capone, Marie Pierre Piccinni, Francesco Annunziato, Paola Guglielmelli, null null
Compassionate use of JAK1/2 inhibitor ruxolitinib for severe COVID-19: a prospective observational study. Leukemia 35 (4) (2020)
Gabriele Todisco, Maria Creignou, Anna Galli, Paola Guglielmelli, Elisa Rumi, Marco Roncador, Ettore Rizzo, Yasuhito Nannya, Daniela Pietra, Chiara Elena, Elisa Bono, Elisabetta Molteni, Vittorio Rosti, Silvia Catricalá, Martina Sarchi, Marios Dimitriou, Johanna Ungerstedt, Alessandro Maria Vannucchi, Eva Hellström-Lindberg, Seishi Ogawa, Mario Cazzola, Luca Malcovati
Co-mutation pattern, clonal hierarchy, and clone size concur to determine disease phenotype of SRSF2P95-mutated neoplasms. Leukemia 35 (8) (2020)
Paola Guglielmelli, Alessandra Carobbio, Elisa Rumi, Valerio De Stefano, Lara Mannelli, Francesco Mannelli, Giada Rotunno, Giacomo Coltro, Silvia Betti, Chiara Cavalloni, Maria Chiara Finazzi, Juergen Thiele, Mario Cazzola, Alessandro Maria Maria Vannucchi, Tiziano Barbui
Validation of the IPSET score for thrombosis in patients with prefibrotic myelofibrosis. Blood cancer journal 10 (2) (2020)
Giacomo Coltro, Francesco Mannelli, Federica Vergoni, Raffaella Santi, Daniela Massi, Luisa Margherita Siliani, Antonella Marzullo, Stefania Bonifacio, Elisabetta Pelo, Annalisa Pacilli, Chiara Paoli, Annalisa Franci, Laura Calabresi, Alberto Bosi, Alessandro Maria Vannucchi, Paola Guglielmelli
Extramedullary blastic transformation of primary myelofibrosis in the form of disseminated myeloid sarcoma: a case report and review of the literature. Clinical and experimental medicine 20 (2) (2020)
Giuseppe Gaetano Loscocco, Francesco Mannelli, Paola Guglielmelli, Chiara Paoli, Ilaria Marone, Rosalba Cucci, Giacomo Coltro, Benedetta Sordi, Francesco Albano, Massimo Breccia, Valerio De Stefano, Guido Finazzi, Alessandra Iurlo, Bruno Martino, Francesca Palandri, Francesco Passamonti, Sergio Siragusa, Lara Mannelli, Duccio Fantoni, Paola Fazi, Sergio Amadori, Marco Vignetti, Tiziano Barbui, Alessandro Maria Maria Vannucchi
Italian survey on clinical practice in myeloproliferative neoplasms. A GIMEMA Myeloproliferative Neoplasms Working Party initiative. American journal of hematology 94 (9) (2019)
Giada Rotunno, Carmela Mannarelli, Giada Brogi, Annalisa Pacilli, Francesca Gesullo, Francesco Mannelli, Sara Fiaccabrino, Benedetta Sordi, Chiara Paoli, Ilaria Marone, Elisa Rumi, Rossella Manfredini, Giovanni Barosi, Mario Cazzola, Alessandro Maria Maria Vannucchi, Paola Guglielmelli
Spectrum of ASXL1 mutations in primary myelofibrosis: prognostic impact of the ASXL1 p.G646Wfs*12 mutation. Blood 133 (26) (2019)
Monia Marchetti, Arianna Ghirardi, Arianna Masciulli, Alessandra Carobbio, Francesca Palandri, Nicola Vianelli, Elena Maria Elli, Silvia Betti, Ambra Di Veroli, Alessandra Iurlo, Daniele Cattaneo, Guido Finazzi, Massimiliano Bonifacio, Luigi Scaffidi, Andrea Patriarca, Elisa Rumi, Ilaria Carola Casetti, Clemency Stephenson, Paola Guglielmelli, Elena Maria Elli, Miroslava Palova, Davide Rapezzi, Daniel Erez, Montse Gomez, Kai Wille, Manuel Perez-Encinas, Francesca Lunghi, Anna Angona, Maria Laura Fox, Eloise Beggiato, Giulia Benevolo, Giuseppe Carli, Rossella Cacciola, Mary Frances McMullin, Alessia Tieghi, Valle Recasens, Susanne Isfort, Fabrizio Pane, Valerio De Stefano, Martin Griesshammer, Alberto Alvarez-Larran, Alessandro Maria Vannucchi, Alessandro Rambaldi, Tiziano Barbui
Second cancers in MPN: Survival analysis from an international study. American journal of hematology 95 (3) (2019)
Francesco Mannelli, Francesca Gesullo, Giada Rotunno, Annalisa Pacilli, Lisa Pieri, Paola Guglielmelli, Alessandro Maria Maria Vannucchi
Validation of the Mayo alliance prognostic system for mastocytosis. Blood cancer journal 9 (2) (2019)
Paola Guglielmelli, Annalisa Pacilli, Giacomo Coltro, Francesco Mannelli, Lara Mannelli, Elisa Contini, Giada Rotunno, Niccolo Bartalucci, Sara Fiaccabrino, Benedetta Sordi, Giuseppe Gaetano Loscocco, Chiara Paoli, Alessandro Maria Maria Vannucchi
Characteristics and clinical correlates of NFE2 mutations in chronic Myeloproliferative neoplasms. American journal of hematology 95 (1) (2019)
Elda Mimiola, Riccardo Bomben, Giovanna De Matteis, Omar Perbellini, Paola Guglielmelli, Massimiliano Bonifacio, Alice Parisi, Valter Gattei, Alberto Zamò, Francesco Mannelli, Andrés Celestino García Montero, Roberta Zanotti
Systemic mastocytosis associated with myelodysplastic/myeloproliferative neoplasms with ring sideroblasts and thrombocytosis: Report of three cases. Hematological oncology 37 (5) (2019)
Tiziano Barbui, Arianna Ghirardi, Arianna Masciulli, Alessandra Carobbio, Francesca Palandri, Nicola Vianelli, Valerio De Stefano, Silvia Betti, Ambra Di Veroli, Alessandra Iurlo, Daniele Cattaneo, Federica Delaini, Massimiliano Bonifacio, Luigi Scaffidi, Andrea Patriarca, Elisa Rumi, Ilaria Carola Casetti, Clemency Stephenson, Paola Guglielmelli, Elena Maria Elli, Miroslava Palova, Laura Bertolotti, Daniel Erez, Montse Gomez, Kai Wille, Manuel Perez-Encinas, Francesca Lunghi, Anna Angona, Maria Laura Fox, Eloise Beggiato, Giulia Benevolo, Giuseppe Carli, Rossella Cacciola, Mary Frances McMullin, Alessia Tieghi, Valle Recasens, Monia Marchetti, Martin Griesshammer, Alberto Alvarez-Larran, Alessandro Maria Maria Vannucchi, Guido Finazzi
Second cancer in Philadelphia negative myeloproliferative neoplasms (MPN-K). A nested case-control study. Leukemia 33 (8) (2019)
Emanuela Sant'Antonio, Paola Guglielmelli, Lisa Pieri, Massimo Primignani, Maria Luigia Randi, Claudia Santarossa, Elisa Rumi, Francisco Cervantes, Federica Delaini, Alessandra Carobbio, Silvia Betti, Elena Rossi, Noa Lavi, Claire N Harrison, Natalia Curto-Garcia, Heinz Gisslinger, Bettina Gisslinger, Giorgina Specchia, Alessandra Ricco, Nicola Vianelli, Nicola Polverelli, Maya Koren-Michowitz, Marco Ruggeri, Francois Girodon, Martin Ellis, Alessandra Iurlo, Francesco Mannelli, Lara Mannelli, Benedetta Sordi, Giuseppe Gaetano Loscocco, Mario Cazzola, Valerio De Stefano, Tiziano Barbui, Ayalew Tefferi, Alessandro Maria Maria Vannucchi
Splanchnic vein thromboses associated with myeloproliferative neoplasms: An international, retrospective study on 518 cases. American journal of hematology 95 (2) (2019)
Francesco Mannelli, Francesca Gesullo, Giada Rotunno, Annalisa Pacilli, Sara Bencini, Francesco Annunziato, Roberta Zanotti, Luigi Scaffidi, Fiorina Giona, Michelina Santopietro, Federica Grifoni, Lisa Pieri, Paola Guglielmelli, Alessandro Maria Maria Vannucchi
Myelodysplasia as assessed by multiparameter flow cytometry refines prognostic stratification provided by genotypic risk in systemic mastocytosis. American journal of hematology 94 (8) (2019)
Barbara Mora, Paola Guglielmelli, Elisa Rumi, Margherita Maffioli, Daniela Barraco, Alessandro Rambaldi, Marianna Caramella, Rami S Komrokji, Jean-Jacques Kiladjian, Jason Gotlib, Alessandra Iurlo, Francisco Cervantes, Timothy Devos, Francesca Palandri, Valerio De Stefano, Marco Ruggeri, Richard T Silver, Francesco Albano, Giulia Benevolo, Chiara Cavalloni, Silvia Uccella, Raffaella Accetta, Claudia Siracusa, Stefania Agnoli, Michele Merli, Tiziano Barbui, Lorenza Bertù, Mario Cazzola, Alessandro Maria Maria Vannucchi, Francesco Passamonti
Impact of bone marrow fibrosis grade in post-polycythemia vera and post-essential thrombocythemia myelofibrosis: A study of the MYSEC group. American journal of hematology 95 (1) (2019)
Ayalew Tefferi, Paola Guglielmelli, Animesh Pardanani, Alessandro M Vannucchi
Myelofibrosis Treatment Algorithm 2018. Blood cancer journal 8 (8) (2018)
Daniela Barraco, Barbara Mora, Paola Guglielmelli, Elisa Rumi, Margherita Maffioli, Alessandro Rambaldi, Marianna Caramella, Rami Komrokji, Jason Gotlib, Jean Jacques Kiladjian, Francisco Cervantes, Timothy Devos, Francesca Palandri, Valerio De Stefano, Marco Ruggeri, Richard T Silver, Giulia Benevolo, Francesco Albano, Michele Merli, Daniela Pietra, Tiziano Barbui, Giada Rotunno, Mario Cazzola, Toni Giorgino, Alessandro Maria Vannucchi, Francesco Passamonti
Gender effect on phenotype and genotype in patients with post-polycythemia vera and post-essential thrombocythemia myelofibrosis: results from the MYSEC project. Blood cancer journal 8 (10) (2018)
Valerio De Stefano, Alessandra Carobbio, Vincenzo Di Lazzaro, Paola Guglielmelli, Alessandra Iurlo, Maria Chiara Finazzi, Elisa Rumi, Francisco Cervantes, Elena Maria Elli, Maria Luigia Randi, Martin Griesshammer, Francesca Palandri, Massimiliano Bonifacio, Juan-Carlos Hernandez-Boluda, Rossella Cacciola, Palova Miroslava, Giuseppe Carli, Eloise Beggiato, Martin H Ellis, Caterina Musolino, Gianluca Gaidano, Davide Rapezzi, Alessia Tieghi, Francesca Lunghi, Giuseppe Gaetano Loscocco, Daniele Cattaneo, Agostino Cortelezzi, Silvia Betti, Elena Rossi, Guido Finazzi, Bruno Censori, Mario Cazzola, Marta Bellini, Eduardo Arellano-Rodrigo, Irene Bertozzi, Parvis Sadjadian, Nicola Vianelli, Luigi Scaffidi, Montse Gomez, Emma Cacciola, Alessandro M Vannucchi, Tiziano Barbui
Benefit-risk profile of cytoreductive drugs along with antiplatelet and antithrombotic therapy after transient ischemic attack or ischemic stroke in myeloproliferative neoplasms. Blood cancer journal 8 (3) (2018)
Alessandro Maria Maria Vannucchi, Paola Guglielmelli
The JAK2 46/1 (GGCC) MPN-predisposing haplotype: A risky haplotype, after all. American journal of hematology 94 (3) (2018)
Annalisa Pacilli, Giada Rotunno, Carmela Mannarelli, Tiziana Fanelli, Alessandro Pancrazzi, Elisa Contini, Francesco Mannelli, Francesca Gesullo, Niccolo Bartalucci, Giuditta Corbizi Fattori, Chiara Paoli, Alessandro Maria Maria Vannucchi, Paola Guglielmelli
Mutation landscape in patients with myelofibrosis receiving ruxolitinib or hydroxyurea. Blood cancer journal 8 (12) (2018)
Chiara Rossi, Roberta Zini, Sebastiano Rontauroli, Samantha Ruberti, Zelia Prudente, Greta Barbieri, Elisa Bianchi, Simona Salati, Elena Genovese, Niccolo Bartalucci, Paola Guglielmelli, Enrico Tagliafico, Vittorio Rosti, Giovanni Barosi, Alessandro Maria Maria Vannucchi, Rossella Manfredini, null null
Role of TGF-β1/miR-382-5p/SOD2 axis in the induction of oxidative stress in CD34+ cells from primary myelofibrosis. Molecular oncology 12 (12) (2018)
Alessandro Maria Maria Vannucchi, Paola Guglielmelli
Traffic lights for ruxolitinib. Blood 130 (9) (2018)
Tiziano Barbui, Jürgen Thiele, Heinz Gisslinger, Hans Michael Kvasnicka, Alessandro M Vannucchi, Paola Guglielmelli, Attilio Orazi, Ayalew Tefferi
The 2016 WHO classification and diagnostic criteria for myeloproliferative neoplasms: document summary and in-depth discussion. Blood cancer journal 8 (2) (2018)
Ayalew Tefferi, Paola Guglielmelli, Maura Nicolosi, Francesco Mannelli, Mythri Mudireddy, Niccolo Bartalucci, Christy M Finke, Terra L Lasho, Curtis A Hanson, Rhett P Ketterling, Kebede H Begna, null Naseema Gangat, Animesh Pardanani, Alessandro M Vannucchi
GIPSS: genetically inspired prognostic scoring system for primary myelofibrosis. Leukemia 32 (7) (2018)
Annalisa Pacilli, Tiziana Fanelli, Carmela Mannarelli, Giada Rotunno, Alessandro Pancrazzi, Alessandro Maria Maria Vannucchi, Paola Guglielmelli
Clonal architecture of JAK2V617F mutated cells during treatment with ruxolitinib. Hematological oncology 36 (1) (2017)
F Passamonti, Toni Giorgino, B Mora, Paola Guglielmelli, E Rumi, M Maffioli, Alessandro Rambaldi, M Caramella, R Komrokji, J Gotlib, J J Kiladjian, F Cervantes, T Devos, F Palandri, V De Stefano, M Ruggeri, R T Silver, G Benevolo, F Albano, D Caramazza, M Merli, Daniela Pietra, R Casalone, G Rotunno, T Barbui, M Cazzola, A M Vannucchi
A clinical-molecular prognostic model to predict survival in patients with post polycythemia vera and post essential thrombocythemia myelofibrosis. Leukemia 31 (12) (2017)
Roberta Zini, Paola Guglielmelli, Daniela Pietra, Elisa Rumi, Chiara Rossi, Sebastiano Rontauroli, Elena Genovese, Tiziana Fanelli, Laura Calabresi, Elisa Bianchi, Simona Salati, Mario Cazzola, Enrico Tagliafico, Alessandro M Vannucchi, Rossella Manfredini, null null
CALR mutational status identifies different disease subtypes of essential thrombocythemia showing distinct expression profiles. Blood cancer journal 7 (12) (2017)
S Ruberti, E Bianchi, Paola Guglielmelli, S Rontauroli, G Barbieri, L Tavernari, T Fanelli, R Norfo, V Pennucci, G Corbizi Fattori, C Mannarelli, N Bartalucci, B Mora, L Elli, M A Avanzini, C Rossi, S Salmoiraghi, R Zini, S Salati, Z Prudente, V Rosti, F Passamonti, A Rambaldi, S Ferrari, E Tagliafico, A M Vannucchi, Rossella Manfredini
Involvement of MAF/SPP1 axis in the development of bone marrow fibrosis in PMF patients. Leukemia 32 (2) (2017)
Claire N Harrison, Martin Griesshammer, Carole Miller, Tamas Masszi, Francesco Passamonti, Pierre Zachee, Simon Durrant, Fabrizio Pane, Paola Guglielmelli, Srdan Verstovsek, Mark M Jones, Deborah S Hunter, William Sun, Jingjin Li, Mahmudul Khan, Dany Habr, Jean-Jacques Kiladjian
Comprehensive haematological control with ruxolitinib in patients with polycythaemia vera resistant to or intolerant of hydroxycarbamide. British journal of haematology 182 (2) (2017)
Paola Guglielmelli, Annalisa Pacilli, Giada Rotunno, Elisa Rumi, Vittorio Rosti, Federica Delaini, Margherita Maffioli, Tiziana Fanelli, Alessandro Pancrazzi, Daniela Pietra, Silvia Salmoiraghi, Carmela Mannarelli, Annalisa Franci, Chiara Paoli, Alessandro Rambaldi, Francesco Passamonti, Giovanni Barosi, Tiziano Barbui, Mario Cazzola, Alessandro Maria Maria Vannucchi, null null
Presentation and outcome of patients with 2016 WHO diagnosis of prefibrotic and overt primary myelofibrosis. Blood 129 (24) (2017)
V De Stefano, A M Vannucchi, M Ruggeri, F Cervantes, A Alvarez-Larrán, A Iurlo, M L Randi, L Pieri, E Rossi, Paola Guglielmelli, S Betti, E Elli, M C Finazzi, G Finazzi, E Zetterberg, N Vianelli, G Gaidano, I Nichele, D Cattaneo, M Palova, M H Ellis, E Cacciola, A Tieghi, J C Hernandez-Boluda, E Pungolino, G Specchia, D Rapezzi, A Forcina, C Musolino, A Carobbio, M Griesshammer, T Barbui
Splanchnic vein thrombosis in myeloproliferative neoplasms: risk factors for recurrences in a cohort of 181 patients. Blood cancer journal 6 (11) (2016)
Takafumi Shimizu, Lucia Kubovcakova, Ronny Nienhold, Jakub Zmajkovic, Sara C Meyer, Hui Hao-Shen, Florian Geier, Stephan Dirnhofer, Paola Guglielmelli, Alessandro Maria Maria Vannucchi, Jelena D Milosevic Feenstra, Robert Kralovics, Stuart H Orkin, Radek C Skoda
Loss of Ezh2 synergizes with JAK2-V617F in initiating myeloproliferative neoplasms and promoting myelofibrosis. The Journal of experimental medicine 213 (8) (2016)

Paola Guglielmelli.css-eqlu8i{font-size:small;padding-left:4px;} (P Guglielmelli)

Publication Activity (10 Years)

Top Topics

Top Venues

Paola Guglielmelli (P Guglielmelli)